The three areas that middle market life sciences companies should pay specific attention to are supply chains, labor and capital markets. We anticipate a decreased appetite from private investors to pay high company valuations, but an uptick in the number of life sciences startups. This presents an ... READ MORE >
biotech
5 things to know in life sciences: Week of October 11
Even in normal times, being the head of a major agency like the U.S. Food and Drug Administration would be challenging. These are far from normal times, so challenges will likely be even greater for the person expected to be nominated by President Biden. This week we also look at preparing for a pandemic ... READ MORE >
5 things to know in life sciences: Week of July 26
This week we highlight the United States Food and Drug Administration’s approval of an insulin biosimilar and their granting of its status as interchangeable with the name brand drug. This promises significant savings for diabetic patients who often face financial hardships because of the cost of care. We ... READ MORE >
5 things to know in life sciences: Week of March 29
Each week, we highlight five things you need to know about in the life sciences industry. Here’s the latest. 1. FTC challenges biopharma merger as antitrust scrutiny grows Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the ... READ MORE >
5 things to know in life sciences: Week of Feb. 15
In this week’s roundup we look at promising results in a clinical trial leveraging an existing diabetes drug for the treatment of obesity, a new and less invasive treatment for sleep apnea, and a new technology in cardiac catheters. We also examine the impact of the pandemic on oncology trials and the ... READ MORE >
5 things to know in life sciences: Week of Feb. 8
In this week’s roundup, we look at the impact of new COVID-19 variants on existing vaccines for the disease; South Africa made the difficult decision to stop using its most readily available vaccine after it showed limited effectiveness against the variant most common there. This is an important ... READ MORE >
CHART OF THE DAY: How COVID-19 vaccines compare on cold storage requirements
About 100 million people tuned in to the watch the Super Bowl on Sunday – that’s almost four times the number of Americans who have received their first jab of a COVID-19 vaccine. While the world’s largest vaccination effort is not going 100% according to plan, the Centers for Disease Control and ... READ MORE >
5 things to know this week in life sciences: Week of Jan. 11
In this week’s roundup, we take a look at life sciences fundraising totals from 2020, which was a record year for the industry in the capital markets. Silicon Valley Bank provides a detailed look at the numbers and provides insights into what to expect this year. Other news this week included Bluebird ... READ MORE >
5 things to know this week in life sciences: Week of Jan. 4
Each year, pharma companies make updates to their price lists in January. This reliably generates headlines and, occasionally, congressional hearings. In this week’s industry roundup, we take a look at the recent price increases and how they compare to last year’s. We also look at the ongoing battle over ... READ MORE >
5 things to know this week in life sciences: Week of Dec. 21
With approval of Moderna’s COVID-19 vaccine last week for emergency use, many of us are looking forward to getting vaccinated with the hope that it will help us return to a more normal life. While looking forward, this is also a good time to reflect on the decades of work that laid the groundwork for this ... READ MORE >